ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,091Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 463

$546K Total Retail Price of All Prescriptions

Rank: 75 out of 463

350 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 5,911 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

55% of this provider’s prescriptions were for brand-name drugs, compared to an average of 49%.

Prescription Price

$77 was the average price of a prescription from this provider, compared to $131 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
SYNTHROID 770 680 1 2
METFORMIN HCL 397 315 2 3
SIMVASTATIN 255 121 3 7
JANUVIA 210 195 4 6
HUMULIN N 201 179 5 56
GLIPIZIDE ER 152 127 6 52
METOPROLOL TARTRATE 138 105 7 31
NEXIUM 134 134 8 37
NOVOLIN N 132 98 9 160
GLIPIZIDE XL 132 125 9 46
GLIMEPIRIDE 130 124 11 8
HUMALOG 130 112 11 14
LEVOTHYROXINE SODIUM 124 41 13 1
CRESTOR 118 109 14 13
METOPROLOL SUCCINATE 115 108 15 28
CYMBALTA 108 102 16 120
ALCOHOL SWABS 107 107 17 57
INSULIN SYRINGE 107 99 17 18
DIOVAN 97 97 19 42
LISINOPRIL 95 45 20 15
ATORVASTATIN CALCIUM 91 87 21 10
ZOLPIDEM TARTRATE 91 91 21 44
RANITIDINE HCL 90 39 23 107
ZETIA 89 88 24 33
ISOSORBIDE MONONITRATE ER 81 81 25 105
PLAVIX 73 73 26 61
JANUMET 73 73 26 17
LANTUS SOLOSTAR 72 68 28 4
NOVOLOG 70 46 29 53
ESCITALOPRAM OXALATE 67 67 30 103
HUMALOG MIX 75-25 67 67 30 49
AMLODIPINE BESYLATE 64 44 32 12
CLOPIDOGREL 62 62 33 64
SINGLE USE SWAB 62 55 33 58
METHOCARBAMOL 55 40 R 35 253
VYTORIN 55 55 35 83
FUROSEMIDE 55 49 35 25
LIPITOR 55 55 35 60
ENALAPRIL MALEATE 52 42 39 35
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.